Cargando…
Mesenchymal Stem Cell Transfer Suppresses Airway Remodeling in a Toluene Diisocyanate-Induced Murine Asthma Model
PURPOSE: Severe asthma is characterized by high medication requirements to maintain good disease control or by persistent symptoms despite high medication use. The transfer of bone marrow-derived mesenchymal stem cells (BMDMSCs) to the injured lungs is a possible treatment for severe asthma. This st...
Autores principales: | Lee, Shin-Hwa, Jang, An-Soo, Kwon, Ji-Hee, Park, Seong-Kyu, Won, Jong-Ho, Park, Choon-Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121063/ https://www.ncbi.nlm.nih.gov/pubmed/21738887 http://dx.doi.org/10.4168/aair.2011.3.3.205 |
Ejemplares similares
-
Cytokeratin Autoantibodies: Useful Serologic Markers for Toluene Diisocyanate-Induced Asthma
por: Ye, Young-Min, et al.
Publicado: (2006) -
Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry
por: Collins, James J., et al.
Publicado: (2017) -
Association of GSTM1 and GSTT1 Null Genotypes with Toluene Diisocyanate-Induced Asthma
por: Lee, Jong-Uk, et al.
Publicado: (2022) -
Probable Role of Beta 2-Adrenergic Receptor Gene Haplotype in Toluene Diisocyanate-Induced Asthma
por: Ye, Young-Min, et al.
Publicado: (2010) -
Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma.
por: Park, H. S., et al.
Publicado: (1998)